CARLA DYER: Open Payments
NPI 1033468939 · SANDY HOOK, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,375 in 102 payments from 12 companies in 2025. Trend: 2023 $1,050 · 2024 $1,419 · 2025 $2,375
Food & beverage: $2,264Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $433 |
| ABBVIE INC. | 25 | $400 |
| Vanda Pharmaceuticals Inc. | 17 | $352 |
| Janssen Pharmaceuticals, Inc | 8 | $255 |
| Otsuka America Pharmaceutical, Inc. | 11 | $250 |
| Teva Pharmaceuticals USA, Inc. | 6 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Lundbeck LLC | 5 | $87 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
Products named: VRAYLAR, ARISTADA, HETLIOZ, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, CAPLYTA, LYBALVI.
Industry payments across KY — which companies pay providers there.
